|
#RareDiseasesNews:Rare Diseases drugs development, marketing & pricing are always surrounded by mist. New challenges for phycians, patients, researchers, pharma & regulators. How do we make the #OrphanDrug maket more effective to all stakeholders? Learn more HERE 
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
June 2017
Categories |
- About US
-
Research
- WP1 Executive Commitee
- WP2 CDG Diagnosis
- WP3 CDG Genetics
- WP4 Biology to guide CDG therapies >
- WP5 Systems Biology and Bioinformatics >
- WP6 Clinical & Therapeutic CDG research >
- WP7 CDG psychology and educational research >
- WP8 CDG Lobby and Representation >
- WP9 Communication & Dissemination >
- WP10 Donations and funds
- WP11 Collaborations & Open positions
- WP12 Advisory committee
- Resources
- EDUCATION
-
Awareness
- Community
- Events
- DONATE
- BLOG
RSS Feed
- About US
-
Research
- WP1 Executive Commitee
- WP2 CDG Diagnosis
- WP3 CDG Genetics
- WP4 Biology to guide CDG therapies >
- WP5 Systems Biology and Bioinformatics >
- WP6 Clinical & Therapeutic CDG research >
- WP7 CDG psychology and educational research >
- WP8 CDG Lobby and Representation >
- WP9 Communication & Dissemination >
- WP10 Donations and funds
- WP11 Collaborations & Open positions
- WP12 Advisory committee
- Resources
- EDUCATION
-
Awareness
- Community
- Events
- DONATE
- BLOG
